{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:42:52Z","timestamp":1771000972689,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2005,2,16]],"date-time":"2005-02-16T00:00:00Z","timestamp":1108512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:p><jats:bold>Objective\u2003<\/jats:bold> Inhibiting preterm labour at extremely early gestations.<\/jats:p><jats:p><jats:bold>Design\u2003<\/jats:bold> Observational study. Case reports.<\/jats:p><jats:p><jats:bold>Setting\u2003<\/jats:bold> Perinatal Centre Lund University Hospital, South Sweden.<\/jats:p><jats:p><jats:bold>Population\u2003<\/jats:bold> Twenty\u2010five women (13 cases with intact membranes and 12 cases with ruptured) with threatened preterm labour and advanced cervical status before 26 completed weeks of gestation.<\/jats:p><jats:p><jats:bold>Methods\u2003<\/jats:bold> A combination of different drugs was used. Atosiban, an oxytocin antagonist, was the first line drug and was given as an infusion for several days as required. Supportive therapy was also given to most women with subcutaneous injections of the \u03b2\u2010receptor agonist terbutaline (0.25 mg up to six times a day); sulindac, a prostaglandin synthetase inhibitor (200 mg one to two times a day up to a week); and broad\u2010spectrum antibiotics (metronidazole and cefuroxime intravenously for three days and thereafter oral therapy).<\/jats:p><jats:p><jats:bold>Main outcome measures\u2003<\/jats:bold> Prolongation of pregnancy more than 48 hours or 7 days. Neonatal survival.<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold> Prolongation of pregnancy for more than 48 hours to enable administration of corticosteroid therapy was obtained in all but three cases. Eight women were delivered after more than a week from admission. Three neonates died at birth due to obstetric complication or sepsis. The other neonates had normal pH in cord or venous blood at birth. No severe side effects were recorded and in no case did the treatment have to be discontinued due to side effects.<\/jats:p><jats:p><jats:bold>Conclusion\u2003<\/jats:bold> The policy described here is not evidence based, relating only to clinical observations, and as such is of very limited value. However, it seems that with this combined approach to management, some days can be gained by achieving full effect of corticosteroid treatment and prolongation of the pregnancy, hopefully reducing time in the neonatal intensive care in these critical cases. No severe side effects were reported.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2005.00593.x","type":"journal-article","created":{"date-parts":[[2005,2,16]],"date-time":"2005-02-16T22:50:00Z","timestamp":1108594200000},"page":"89-93","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Combination therapy"],"prefix":"10.1111","volume":"112","author":[{"given":"Ingemar","family":"Ingemarsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,2,16]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"Medical Birth Register National Board of Health and Welfare Sweden 2001\u20132002."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/siny.1999.0001"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/sper.2001.27164"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1084-2756(96)80045-5"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1997.tb08921.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2001.080006525.x"},{"key":"e_1_2_6_8_2","first-page":"CD000065","article-title":"Prophylactic corticosteroids for preterm birth","author":"Crowley P","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11476-0"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.1985.tb00640.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2000.tb13259.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-0528.2001.00043.x","article-title":"Effectiveness and safety of the oxytocin antagonist atosiban versus beta\u2010adrenergic agonists in the treatment of preterm labour","volume":"108","author":"The Worldwide Atosiban vs Beta\u2010agonists Study Group","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90163-9"},{"key":"e_1_2_6_14_2","first-page":"223","article-title":"Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor","volume":"79","author":"Carlan SJ","year":"1992","journal-title":"Obstet Gynecol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6934(03)00047-6"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(78)90907-9"},{"issue":"20","key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1471-0528.2003.00034.x","article-title":"Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth","volume":"110","author":"Lamont RF","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"key":"e_1_2_6_18_2","first-page":"CD000246","article-title":"Prophylactic antibiotics for inhibiting preterm labour with intact membranes","author":"King J","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04234-3"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04233-1"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(02)00365-2"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2005.00593.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2005.00593.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T01:53:19Z","timestamp":1694656399000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2005.00593.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,16]]},"references-count":20,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1471-0528.2005.00593.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2005.00593.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,16]]},"assertion":[{"value":"2005-02-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}